Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults

Clinical trial NCT00708110 · COMPLETED

Trial details

NCT number: NCT00708110
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2008-06-01
Primary completion: 2008-08-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.